The discussion will among others: – Define pharmacovigilance and adverse drug reactions in the context of clinical practice. – Differentiate between adverse events and adverse drug reactions. – Recognise factors that increase the risk of adverse drug reactions in patients. – Identify what types of adverse drug reactions should be reported. – Recognise who is responsible for reporting ADRs in clinical practice and more